Trial Profile
Midodrine Use in the Recovery Phase of Septic Shock
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2024
Price :
$35
*
At a glance
- Drugs Midodrine (Primary) ; Vasopressors
- Indications Septic shock
- Focus Therapeutic Use
- 09 Jan 2024 Planned primary completion date changed from 1 Nov 2018 to 2 May 2018.
- 09 Jan 2024 Planned initiation date changed from 1 Jan 2017 to 1 Mar 2017.
- 02 May 2018 Status changed from recruiting to discontinued as the trial was unable to meet enrollment goals.